Nymox Pharmaceutical Corporation Liabilities:
9.599M for Dec. 31, 2012Nymox Pharmaceutical Corporation Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 9.599M |
| Sept. 30, 2012 | 10.27M |
| June 30, 2012 | 10.80M |
| March 31, 2012 | 11.10M |
| Dec. 31, 2011 | 11.97M |
| Sept. 30, 2011 | 12.42M |
| June 30, 2011 | 13.08M |
| March 31, 2011 | 13.72M |
| Dec. 31, 2010 | 16.36M |
| Sept. 30, 2010 | 2.682M |
| June 30, 2010 | 2.476M |
| March 31, 2010 | 2.131M |
| Dec. 31, 2009 | 2.543M |
| Sept. 30, 2009 | 2.196M |
| June 30, 2009 | 2.189M |
| March 31, 2009 | 2.090M |
| Dec. 31, 2008 | 2.057M |
| Sept. 30, 2008 | 2.291M |
| June 30, 2008 | 2.328M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
NYMX Liabilities Benchmarks
| Companies | |
|---|---|
| Acorda Therapeutics | 173.78M |
| Tesaro | 11.63M |
| China Biologic Products | 115.58M |
NYMX Liabilities Rankings
| Overall |
90th percentile 799 of 8007 |
| Sector |
73rd percentile 179 of 685 in Healthcare |
| Industry |
67th percentile 80 of 248 in Biotechnology |
NYMX Liabilities Range, Past 5 Years
| Minimum | 2.057M | Dec 2008 |
| Maximum | 16.36M | Dec 2010 |
| Average | 6.964M |
